ESC 365 - Mr Anders Holt

Speaker illustration

Mr Anders Holt

Copenhagen University Hospital, Copenhagen (Denmark)

Member of:

Presentations Articles

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

Event: ESC Congress 2023

Topic: Public Health

Session: Innovations in public health and health economics (1)

Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines

Event: ESC Congress 2023

Topic: Psychiatric Disorders and Heart Disease

Session: Psychiatric and neurologic disease: cardiovascular complications

Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates

Event: ESC Congress 2021 - The Digital Experience

Topic: Nitrates

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants

Event: ESC Congress 2021 - The Digital Experience

Topic: Anticoagulants

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era - a Danish, nationwide, and registry-based cohort study

Event: ESC Congress 2020

Topic: Beta-Blockers

Session: Young Investigator Award Session Population Sciences

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources